Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.43 USD | -1.29% | +7.88% | -13.84% |
08/05 | Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating | MT |
08/05 | Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.84% | 2.66B | |
+3.63% | 108B | |
+11.08% | 104B | |
+1.28% | 22.33B | |
-12.73% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.36% | 17.64B | |
+3.60% | 14.05B | |
+37.39% | 12.51B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Oppenheimer Adjusts Denali Therapeutics Price Target to $68 From $70, Maintains Outperform Rating